药学学报, 2021, 56(11): 2943-2949
引用本文:
张旋, 肖创, 黄蓉, 邹澄, 陈骋, 王永艳, 陈晨, 李鲜, 杨子峰, 杨为民. 异佛司可林抑制炎症和纤维化细胞因子减轻小鼠肺纤维化作用研究[J]. 药学学报, 2021, 56(11): 2943-2949.
ZHANG Xuan, XIAO Chuang, HUANG Rong, ZOU Cheng, CHEN Cheng, WANG Yong-yan, CHEN Chen, LI Xian, YANG Zi-feng, YANG Wei-min. Isoforskolin alleviates pulmonary fibrosis in mice by inhibiting inflammatory and fibrotic cytokines[J]. Acta Pharmaceutica Sinica, 2021, 56(11): 2943-2949.

异佛司可林抑制炎症和纤维化细胞因子减轻小鼠肺纤维化作用研究
张旋1, 肖创1, 黄蓉1, 邹澄1, 陈骋1, 王永艳1, 陈晨1, 李鲜1, 杨子峰2, 杨为民1*
1. 昆明医科大学药学院暨云南省天然药物药理重点实验室, 云南 昆明 650500;
2. 广州医科大学, 呼吸疾病国家重点实验室, 广东 广州 510180
摘要:
本文旨在探讨异佛司可林 (isoforskolin,ISOF) 对博莱霉素 (bleomycin,BLM) 诱导小鼠肺纤维化 (pulmonary fibrosis,PF) 的影响,并初步探索其作用机制。本研究中动物福利和实验过程均遵循昆明医科大学动物伦理委员会的规定。实验分为假手术组、博莱霉素组 (气管滴入BLM 5 mg·kg-1)、阳性药物对照组 (气管滴入BLM 5 mg·kg-1 + 腹腔注射地塞米松磷酸钠2.5 mg·kg-1)、异佛司可林2.5和10 mg·kg-1组 (气管滴入BLM 5 mg·kg-1 + 灌胃给予异佛司可林2.5和10 mg·kg-1)。给药方式为每日1次,连续给药28天。分别在实验第7天和28天处死小鼠,收集肺组织和支气管肺泡灌洗液标本。苏木精-伊红 (hematoxylin-eosin,H&E) 染色和Masson染色检测肺组织病理变化,碱水解法检测肺组织羟脯氨酸含量,ELISA法 (enzyme-linked immunosorbent assay) 检测支气管肺泡灌洗液中肿瘤坏死因子α (tumor necrosis factor α,TNF-α) 和白细胞介素1β (interleukin 1β,IL-1β) 水平。Western blot法检测肺组织转化生长因子β1 (transforming growth factor β1,TGF-β1) 和结缔组织生长因子 (connective tissue growth factor,CTGF) 蛋白表达。实验结果显示,与博莱霉素组比较,异佛司可林10 mg·kg-1组小鼠肺组织炎症和纤维化程度明显减轻,肺组织羟脯氨酸含量降低,气管灌洗收集肺泡灌洗液 (bronchoalveolar lavage fluid,BALF) 中TNF-α和IL-1β水平下降,肺组织TGF-β1和CTGF蛋白表达下调,差异有统计学意义 (P < 0.05)。结果表明,异佛司可林可通过抑制炎症细胞因子TNF-α和IL-1β释放,下调促纤维化因子TGF-β1和CTGF蛋白表达,通过抗炎与抗纤维化双重作用发挥抗肺纤维化作用。
关键词:    肺纤维化      异佛司可林      炎症细胞因子      转化生长因子β1      结缔组织生长因子     
Isoforskolin alleviates pulmonary fibrosis in mice by inhibiting inflammatory and fibrotic cytokines
ZHANG Xuan1, XIAO Chuang1, HUANG Rong1, ZOU Cheng1, CHEN Cheng1, WANG Yong-yan1, CHEN Chen1, LI Xian1, YANG Zi-feng2, YANG Wei-min1*
1. School of Pharmaceutical Sciences and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, China;
2. State Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou 510180, China
Abstract:
We investigated the therapeutic effect and mechanism of isoforskolin on bleomycin-induced pulmonary fibrosis in mice. The animal welfare and experimental process were in accordance with the Regulations of Animal Ethics Committee of Kunming Medical University. Male Kunming mice were randomly divided into five groups: sham operation group (intratracheal instillation of normal saline), bleomycin group (intratracheal instillation of bleomycin 5 mg·kg-1) , positive drug control group (intratracheal instillation of bleomycin 5 mg·kg-1 + intraperitoneal injection of dexamethasone sodium phosphate 2.5 mg·kg-1), isoforskolin (2.5 and 10 mg·kg-1) groups (intratracheal instillation of bleomycin 5 mg·kg-1 + intragastric administration of isoforskolin 2.5 and 10 mg·kg-1). The method of drug administration was once a day for 28 days. On the 7th and 28th day of the experiment, the mice were killed, and the lung tissue and bronchoalveolar lavage fluid samples were collected. Hematoxylin eosin (H&E) staining and Masson staining were used to detect the pathological changes of lung tissue. The content of hydroxyproline in lung tissue was detected by alkaline hydrolysis method. The levels of tumor necrosis factor α (TNF-α) and interleukin 1β (IL-1β) in bronchoalveolar lavage fluid (BALF) were detected by enzyme linked immunosorbent assay (ELISA). The expressions of transforming growth factor β1 (TGF-β1) and connective tissue growth factor (CTGF) in lung tissue were detected by Western blot. The experimental results showed that compared with the bleomycin group, the degree of inflammation and fibrosis in the lung tissue of mice in 10 mg·kg-1 isoforskolin group was significantly reduced, the content of hydroxyproline in the lung tissue was decreased, the levels of TNF-α and IL-1β in BALF were decreased, and the protein expressions of TGF-β1 and CTGF in the lung tissue were downregulated, the differences were statistically significant (P < 0.05). The results suggest that isoforskolin can inhibit the release of inflammatory cytokines TNF-α and IL-1β, downregulate the protein expression of profibrotic factors TGF-β1 and CTGF, and exert anti pulmonary fibrosis effect through both anti-inflammatory and anti fibrotic effect.
Key words:    pulmonary fibrosis    isoforskolin    inflammatory cytokine    transforming growth factor β1    connective tissue growth factor   
收稿日期: 2021-02-22
DOI: 10.16438/j.0513-4870.2021-0253
基金项目: 国家自然科学基金资助项目(81870037,81460565);云南省科技厅项目(202005AF150043,202005AE160004,2019FD020);广州医科大学呼吸疾病国家重点实验室开放课题(SKLRD-OP-201917).
通讯作者: 杨为民,Tel:86-871-65922780,E-mail:15887299927@yeah.net
Email: 15887299927@yeah.net
相关功能
PDF(2666KB) Free
打印本文
0
作者相关文章
张旋  在本刊中的所有文章
肖创  在本刊中的所有文章
黄蓉  在本刊中的所有文章
邹澄  在本刊中的所有文章
陈骋  在本刊中的所有文章
王永艳  在本刊中的所有文章
陈晨  在本刊中的所有文章
李鲜  在本刊中的所有文章
杨子峰  在本刊中的所有文章
杨为民  在本刊中的所有文章

参考文献:
[1] Nair GB, Matela A, Kurbanov D, et al. Newer developments in idiopathic pulmonary fibrosis in the era of anti-fibrotic medications[J]. Expert Rev Respir Med, 2016, 10: 699-711.
[2] Kolahian S, Fernandez IE, Eickelberg O, et al. Immune mechanisms in pulmonary fibrosis[J]. Am J Respir Cell Mol Biol, 2016, 55: 309-322.
[3] Zhao JK, Yang WM, Yang ZB, et al. Study on general pharmacology of forskolin and isoforskolin[J]. J Kunming Med Univ (昆明医科大学学报), 2014, 35: 37-40.
[4] Wang YQ, Yin JJ, Mao YC, et al. Metabolism and degradation of isoforskolin in human liver microsomes and artificial gastrointestinal fluid[J]. Chin Tradit Pat Med (中成药), 2016, 38: 1244-1248.
[5] Yang W, Qiang D, Zhang M, et al. Isoforskolin pretreatment attenuates lipopolysaccharide-induced acute lung injury in animal models[J]. Int Immunopharmacol, 2011, 11: 683-692.
[6] Lv X, Li K, Hu Z. Autophagy and pulmonary fibrosis[J]. Adv Exp Med Biol, 2020, 1207: 569-579.
[7] Malaviya R, Kipen HM, Businaro R, et al. Pulmonary toxicants and fibrosis: innate and adaptive immune mechanisms[J]. Toxicol Appl Pharmacol, 2020, 409: 115272.
[8] Wei PX, Wang WY, Li YX, et al. The cell cycle inhibitor p21 promote mouse lung fibrosis by activating alveolar macrophages[J]. Acta Pharm Sin (药学学报), 2020, 55: 1792-1800.
[9] Du X, Shi R, Wang Y, et al. Isoforskolin and forskolin attenuate lipopolysaccharide-induced inflammation through TLR4/MyD88/NF-κB cascades in human mononuclear leukocytes[J]. Phytother Res, 2019, 33: 602-609.
[10] Zhao H, Liu A, Shen L, et al. Isoforskolin downregulates proinflammatory responses induced by Borrelia burgdorferi basic membrane protein A[J]. Exp Ther Med, 2017, 14: 5974-5980.
[11] Hua HH, Chen DQ, Wang YN, et al. New insights into TGF-β/Smad signaling in tissue fibrosis[J]. Chem Biol Interact, 2018, 292: 76-83.
[12] Chen C, Zhang X, Hong ZP. Research progress of key cells and molecules in the formation of pulmonary fibrosis[J]. Basic Clin Med (基础医学与临床), 2018, 38: 1329-1332.
[13] Liang X, Wang J, Chen W, et al. Inhibition of airway remodeling and inflammation by isoforskolin in PDGF-induced rat ASMCs and OVA-induced rat asthma model[J]. Biomed Pharmacother, 2017, 95: 275-286.
[14] Liang RJ. Study on the effects of aerosolized budesonide on the expression of TGF-β and CTGF in lung tissue of rats with pulmonary fibrosis[J]. J North Pharm (北方药学), 2018, 15: 158-159.
相关文献:
1.宋宇, 张慧, 刘瑞丽, 海广范, 王童, 岳佳新, 张炜丽, 任禹珂.钩藤碱通过抑制Smad信号通路磷酸化减轻腹腔粘连发生的作用机制[J]. 药学学报, 2017,52(2): 229-235